ATE459886T1 - Verfahren zur vorhersage der metastasefähigkeit von mammakarzinom - Google Patents

Verfahren zur vorhersage der metastasefähigkeit von mammakarzinom

Info

Publication number
ATE459886T1
ATE459886T1 AT04740845T AT04740845T ATE459886T1 AT E459886 T1 ATE459886 T1 AT E459886T1 AT 04740845 T AT04740845 T AT 04740845T AT 04740845 T AT04740845 T AT 04740845T AT E459886 T1 ATE459886 T1 AT E459886T1
Authority
AT
Austria
Prior art keywords
metastasic
predicting
ability
mammary carcinoma
sample
Prior art date
Application number
AT04740845T
Other languages
English (en)
Inventor
Vesna Evtimova
Ulrich Weidle
Robert Zeillinger
Original Assignee
Robert Zeillinger
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robert Zeillinger filed Critical Robert Zeillinger
Application granted granted Critical
Publication of ATE459886T1 publication Critical patent/ATE459886T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT04740845T 2003-07-11 2004-07-09 Verfahren zur vorhersage der metastasefähigkeit von mammakarzinom ATE459886T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03015584 2003-07-11
PCT/EP2004/007561 WO2005005989A1 (en) 2003-07-11 2004-07-09 A method for predicting the metastatic potential of breast cancer

Publications (1)

Publication Number Publication Date
ATE459886T1 true ATE459886T1 (de) 2010-03-15

Family

ID=34042827

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04740845T ATE459886T1 (de) 2003-07-11 2004-07-09 Verfahren zur vorhersage der metastasefähigkeit von mammakarzinom

Country Status (4)

Country Link
EP (1) EP1646874B1 (de)
AT (1) ATE459886T1 (de)
DE (1) DE602004025812D1 (de)
WO (1) WO2005005989A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006235264A1 (en) * 2005-04-07 2006-10-19 Novartis Vaccines And Diagnostics Inc. DDR2 in cancer diagnosis, detection and treatment
WO2008070090A2 (en) 2006-12-05 2008-06-12 Oncomed Pharmaceuticals, Inc. Compositions and methods for diagnosing and treating cancer
WO2008086800A2 (en) * 2007-01-15 2008-07-24 Aarhus Universitet Predisposition to, prognosis for and treatment of breast cancer relating to human chromosome 16
WO2008086799A1 (en) * 2007-01-15 2008-07-24 Aarhus Universitet Predisposition to, prognosis for and treatment of breast cancer relating to human chromosome 1 (presence)
US20100145131A1 (en) * 2007-05-01 2010-06-10 Helena Grinberg-Rashi Methods and kits for predicting cancer metastasis
EP3364190A1 (de) * 2017-02-20 2018-08-22 Panka Cancer Research AG Verfahren zum nachweis von krebs oder krebszellen
JP7561129B2 (ja) * 2018-12-21 2024-10-03 アイオーニス ファーマシューティカルズ， インコーポレーテッド Ｐｍｐ２２の発現を低減するための化合物及び方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6680175B2 (en) * 1998-05-05 2004-01-20 Adherex Technologies, Inc. Methods for diagnosing and evaluating cancer

Also Published As

Publication number Publication date
DE602004025812D1 (de) 2010-04-15
WO2005005989A1 (en) 2005-01-20
EP1646874B1 (de) 2010-03-03
EP1646874A1 (de) 2006-04-19

Similar Documents

Publication Publication Date Title
Ozawa et al. Prognostic significance of CD44 variant 2 upregulation in colorectal cancer
DE60043896D1 (de) Verfahren zum nachweis von lungenneoplasmen in fäkalen proben
DE60226271D1 (de) Verfahren zum nachweis von prostatakrebs
NO20074389L (no) Bestemmelse av respondere til kjemoterapi
ATE508753T1 (de) Assays und verfahren unter verwendung von biomarkern
ATE515575T1 (de) Verfahren und sonden für den nachweis von krebs
EA200701804A1 (ru) Мутации рецептора эпидермального фактора роста
DE602006002809D1 (de) Verfahren zur erkennung eines ovarialkarzinoms
ATE483825T1 (de) Zusammensetzungen für die identifizierung von adenoviren
ATE426167T1 (de) Auto-antikírper gegen annexin-proteine als marker fur lungenkrebs
WO2005118876A3 (en) Egfr mutations
DE69719057D1 (de) Verfahren zur signalverstärkung
ATE397098T1 (de) Verfahren zur diagnostik von eierstock endometriose
ATE426043T1 (de) Verfahren zur identifizierung des brustkrebsrisikos
ATE459886T1 (de) Verfahren zur vorhersage der metastasefähigkeit von mammakarzinom
EP1794318A4 (de) Arzneistoff-screening und molekularer diagnosetest zum frühen nachweis von kolorektalkarzinom: reagentien, verfahren und kits dafür
DK1049465T3 (da) Anvendelse af inhibitorer til behandling af RTK-hyperfunktionsbetingede forstyrrelser, især af kræft
TW200626900A (en) Wnt proteins and detection and treatment of cancer
ATE508205T1 (de) Tests und verfahren unter verwendung von biomarkern
WO2003073821A3 (en) Shc PROTEIN-RELATED METHODS AND COMPOSITIONS FOR THE PROGNOSIS OF BREAST, PROSTATE AND OVARIAN CANCER
DE502004012314D1 (de) Verfahren zum reaktiv-färben von leder, sowie farbstoffe und deren verwendung
Chen et al. High-throughput flow cytometry screening of human hepatocellular carcinoma reveals CD146 to be a novel marker of tumor-initiating cells
WO2005002414A3 (en) Prognosis determination in ewing sarcoma patients by means of genetic profiling
DE50212790D1 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper
ATE412053T1 (de) Verfahren zum nachweis von krebs

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1646874

Country of ref document: EP